The chemical composition of the volatile oil from berries of Croton macrostachyus Hochst. ex Del. was determined by GC and GC/MS. The oil was tested for its in vitro antileishmanial activity on two Leishmania strains, and its toxicity on the human monocytic leukemia (THP-1) cell line and erythrocytes from sheep blood. The main constituents of the oil were benzyl benzoate (51.8%), linalool (10.1%), γ-muurolene (9.3%), (E,E)-α-farnesene (3.2%), δ-cadinene (2.8%) and α-curcumene (2.7%). The oil was effective against L. donovani and L. aethiopica promastigotes (MIC = 0.08 µL/mL and 0.16 µL/mL, respectively) and axenic amastigote stages (EC 50 = 20.00 nL/mL and 6.66 nL/mL, respectively). The CC 50 value for the oil was 10.00 nL/mL on THP-1 cells with selectivity index values of 0.5 for L. donovani and 1.5 for L. aethiopica. The median lethal concentration (LC 50 ) of the oil was 2.45 µL/mL. Thus the observed high efficacy and moderate toxicity of the volatile oil from C. macrostachyus, makes the plant a promising source of new lead compounds in the search for safe and effective antileishmanial drugs.
Leishmaniasis is a vector-borne parasitic disease affecting more than 12 million people worldwide existing in many clinical forms [6] . In Ethiopia, visceral leishmaniasis caused by L. donovani occurs in arid and semi-arid lowland areas. Some highland areas are also endemic to cutaneous leishmaniasis, which is mainly caused by L. aethiopica [7] . Treatment of the disease with available first-line drugs in endemic areas is expensive and becoming unsatisfactory due to increased treatment failure, significant toxicity and growing drug resistance [8, 9] . Intensive research is in progress with the intention to discover new leishmaniacidal agents with diverse chemical structures and novel mechanisms of action.
The present study investigated the chemical constituents of the volatile oil obtained from berries of C. macrostachyus using GC and GC/MS, and the in vitro leishmaniacidal activity and toxicity profile of the oil on isolated parasites and cells. To the best of our knowledge, this is the first report on the composition of the volatile oil from fruits of C. macrostachyus.
The oil was yellow in color and obtained in a yield of 0.038%. The results from GC and GC/MS analysis of the chemical composition of C. macrostachyus volatile oil are presented in Table 1 . Seventy-two compounds representing 99.7% of the total volatile oil constituents were characterized, of which 11 were only structurally annotated (sesquiterpenes, aromatic compounds).
Major identified components were benzyl benzoate (51.8%), linalool (10.1%), γ-muurolene (9.3%), (E,E)α-farnesene (3.2%), δ-cadinene (2.8%) and αcurcumene (2.7%). The oil contained aromatic compounds (52.5%), sesquiterpene hydrocarbons (24.0%), oxygenated monoterpenes (10.6%), oxygenated sesquiterpenes (10.9%), monoterpene hydrocarbons (1.0%), and straight-chain aliphatic structures (0.7%). The occurrence of benzoic esters has been described for a few other Croton species (C. oligandrus Pierre ex Hutch. [10] and C. jimenezii Standl. & Valerio [11] ), but high amounts of benzyl benzoate have also been detected in the volatile oils from other species of Euphorbiaceae [12] . Moreover, high levels of benzoic acid esters, and specifically Table 2 : The in vitro antileishmanial activity of essential oils from berries of C. macrostachyus against promastigote and axenic amastigote forms of L. donovani and L. aethiopica, and toxicity profile on the human monocytic leukemia cell line (THP-1) and sheep erythrocytes. benzyl benzoate, are commonly detected in fruits and berries, and have been reported from several other plant families [13] [14] [15] . High levels of certain oxygenated monoterpenes and sesquiterpene hydrocarbons, as found in our study, have been described in other Croton species, such as linalool [16, 17] and γ-muurolene [18] . Generally, C. macrostachyus oil was rich in aromatic structures and oxygenated terpenes, indicating potentially high antimicrobial properties and biological activity [19] .
The volatile oil caused growth inhibition of promastigote forms of L. donovani (MIC = 0.08 µL/mL) and L. aethiopica (MIC = 0.16 µL/mL). Activities observed were comparable with that of the most potent antileishmanial drug, amphotericin B, indicating quite strong inhibitory effects. The leishmanicidal effect against the axenic amastigote stages of L. donovani (EC 50 = 20.00 nL/mL) and L. aethiopica (EC 50 = 6.66 nL/mL) was similar to that of common reference drugs, such as sodium stibogluconate and paromomycin sulfate. Thus, the volatile oil showed promising antileishmanial properties against multiplying amastigotes, i.e. in infected cells and affected tissues. The median cytotoxic concentration (CC 50 ) of the volatile oil was 10.00 nL/mL. SI data for the axenic amastigote forms showed that the oil was 0.5 times and 1.5 times less toxic against THP-1 cells compared with L. donovani and L. aethiopica, respectively. Results from other studies with 12 different essential oils showed similar SI values [20] , although Melissa, Thymus and Melaleuca oil exerted strong antileishmanial activity. Except for pentamidine isethionate, SI values of our tested reference drugs ranged higher compared with the volatile oil. Moreover, the oil also had a median lethal concentration (LC 50 ) of 2.45 µL/mL, comparable to that of amphotericin B, while the LC 50 indicated a strong hemolytic activity compared with the same reference drug. Based on these results, potential medicinal applications of Croton macrostachyus essential oil might be restricted to cutaneous leishmaniasis.
A number of reports indicated that volatile oils of plant origin are potential leishmanicidal agents. Isolated mono-and sesquiterpenes from Melissa officinalis, Thymus vulgaris, Melaleuca alternifolia [20] , Chenopodium ambrosioides [21] , and Annona foetida [22] , and volatile oils containing either linalool [17] or eugenol [23] as their major constituents, showed strong antileishmanial properties. The potential leishmanicidal effect of monoterpenes, such as thymol [24] , sesquiterpenes, such as nerolidol [25] , diterpenoids [26] and triterpenoids was also indicated. In addition, Cymbopogon citratus [27] and Ocimum gratissimum oils [28] showed effects on the related protozoan species
Crithidia deanei and Herpetomonas samuelpessoai, respectively. Volatile oil constituents are lipophilic, potentially exerting leishmanicidal effects by disturbing the cell membrane and affecting other cellular structures of the parasite [17, 27] , making them more permeable, by interrupting specific metabolic pathways, such as inhibition of the biosynthesis of Leishmania lipids (isoprenoids, dolichol, ergosterol, and ubiquinones) [25] , agglutination of lectins [27] or enhancing production of nitric oxide [17] in leishmania infected macrophages. Therefore, the observed strong antileishmanial activity and moderate toxicity profile of C. macrostachyus oil could arise from constituents based on either one or several of the mechanisms described above. Previous studies on aerial parts of C. macrostachyus also revealed their immune stimulating [29] , antihelmintic [30] , antinociceptive, antiinflammatory [31] , antibacterial and cytotoxic activities [32] . Similar studies on volatile constituents of different Croton sp. indicated their antihelmintic [33] , antinociceptive [34] , antifungal [35] , antibacterial and antioxidant activities [36] .
This study disclosed strong leishmanicidal activity of the essential oil of Croton macrostachyus and simultaneously, moderate cytotoxicity and hemolytic properties. Our findings support the traditional medicinal use of the plant for treatment of leishmaniasis. However, based on the cytotoxicity and hemolytic activity of the oil, further studies are required in order to isolate and identify promising constituents of the oil with regard to their potential leishmanicidal activity vs. toxicity, and the underlying mechanism of action both in vitro and in vivo.
Experimental

Plant material: Berries of Croton macrostachyus
Hochst. ex Del. were collected in Addis Ababa, Ethiopia, in December, 2006. The plant was authenticated by a plant taxonomist and voucher specimens were deposited (YT 006/06) at the National Herbarium, Addis Ababa University, Ethiopia.
Isolation of volatile oil:
Hydrodistillation of fresh berries of C. macrostachyus (400 g) was carried out using a glass type Clevenger apparatus for 3 h after the mixture started boiling. The oil was carefully separated; the yield was calculated and the oil finally stored in an opaque glass vial in a refrigerator at -20°C prior to analysis and biological assays.
Gas chromatography analysis of volatile oil:
Analyses of the volatile oil were achieved using a Varian Star 3400CX gas chromatograph equipped with a fused silica Chrompack WCOT CP-Sil-5 capillary column (30 m × 0.32 mm i.d. with a film thickness of 0.25 µm) and automatic injector in splitless mode, coupled with a Varian Saturn 3 mass spectrometer (ionization voltage 70 eV). The oven temperature was held at 40°C for 3 min, then programmed from 40 to 220°C at a rate of 3°C/min, and then held at 220°C for 3 min. The carrier gas was helium (5 psi) at 50 mL/min through the injector and 30 cm/sec through the column. The injector and MS detector temperature were both set at 220°C, and a mass range of m/z=40-400 was recorded. All MS were acquired in EI mode. Essential oil compounds in the volatile oil were identified using a combination of a MS data base search (IMS Terpene Library 1989; NIST/EPA/NIH Mass Spectral Library 2005), relative retention index (ESO Database of essential oils) and comparison of MS found in the literature [37] . Quantitative analysis (in %) was performed by peak area normalization measurements (TIC=total ion count). Reference drugs: Reference drugs used were amphotericin B (Fungizon®, Bristol-Myers Squibb, Rueil-Malmaison, France), sodium stibogluconate (Albert David Ltd., Kolkata, India), paromomycin sulfate (Gland Pharma, Hydrabad, India) and pentamidine isethionate (Sigma Chemical Co., St. Louis, USA).
Test strains and cell lines: Isolates of
Preparation of stock solutions:
Stock solutions of volatile oil (100 µL/mL in DMSO) and the reference drugs amphotericin B (5 mg/mL in PBS), sodium stibogluconate (100 mg/mL), paromomycin sulfate (500 mg/mL) and pentamidine isethionate (25 µg/mL in DMSO) were prepared. The prepared solutions were kept in a refrigerator at -20°C until used.
Culture conditions;
Promastigote culture: L. aethiopica and L. donovani isolates were grown in tissue culture flasks containing RPMI 1640 medium (Gibco, Invitrogen Co., UK), supplemented with 10% heat-inactivated fetal calf serum (HIFCS) (Gibco, Invitrogen Co., UK), and 100 IU penicillin/mL and 100 μg/mL streptomycin solution (Sigma Chemical Co., St. Louis, USA) at 22°C for L. aethiopica [38] and 26°C for L. donovani [39] , following previously described methods.
Cell line culture:
The human leukemia monocyte THP-1 cells were cultured in RPMI-1640 supplemented with 10% HIFCS, 100 U/mL penicillin, 100 μg/mL streptomycin and 0.25 μg/mL amphotericin B in a humidified 5% CO 2 incubator at 37°C, as previously described [38] .
Axenic amastigote culture:
The axenic cultures were raised following the methods described for L. aethiopica [38] and L. donovani [40] , with minor modifications. Promastigotes in late stationary phase were centrifuged and re-suspended in medium 199 containing Hank's balanced salts, supplemented with 20% heat inactivated fetal calf serum (HIFCS), 2 mM L-glutamine, 50 IU/mL penicillin, and 50 μg/mL streptomycin; the pH was adjusted to 5.5 (for both strains) using 0.10 N HCl. The cells were then incubated at either 31°C (for L. aethiopica) or 37°C (for L. donovani) in a humidified 5% CO 2 incubator for 7 days.
Biological assays; Antipromastigote assay:
In a 96well microtitre plate, volatile oil was serially diluted to twice the final test concentrations (0.00244 to 5.0 µL/mL) in 100 µL culture medium with each test concentration in duplicate. Then, 100 µL of suspensions containing 3.5 × 10 6 promastigotes/mL in a logarithmic phase were added to each well. Contents of the plates were then maintained at 22°C (for L. aethiopica) and 26°C (for L. donovani) in a 5% CO 2 incubator. The cell density, motility and morphology for each treatment were determined daily with an inverted microscope and the antileishmanial activity was expressed as the MIC values after 72 h of incubation. The reference drugs and medium with 1% DMSO were included as controls.
Antiamastigote assay: The antiamastigote assay for the oils tested followed a previously established method [41] . In a 96-well microtitre plate, test substances were serially diluted to final test concentrations of 0.000228 to 0.5 µL/mL in 50 µL culture medium, and 50 µL suspension containing 2 × 10 7 cells/mL axenic amastigotes was added to each well. Contents of the plates were then incubated in a humidified 5% CO 2 incubator at either 31°C (for L. aethiopica) or 37°C (for L. donovani) for 72 h. After 68 h of incubation, 10 µL of fluorochrome resazurin (Sigma Chemical Co., St. Louis, USA) solution (12.5 µg dissolved in 100 mL of PBS, pH=7.2) was added to each well and the fluorescence intensity was measured after a total incubation time of 72 h using a Victor 3 Multilabel Reader (PerkinElmer) at an excitation wavelength of 530 nm and emission wavelength of 590 nm. Assays with standard antileishmanial drugs and medium with 1% DMSO were also performed as controls. The background fluorescence intensity of each oil and reference drug was also measured.
Cytotoxicity assay; Cell line (THP-1) viability assay:
Serial dilution and the assay were performed as indicated for the antiamastigote assay, except that 50 µL suspensions containing 1 × 10 6 THP-1 cells were added to each well and incubated in 5% CO 2 -air mixture at 37°C for 72 h.
Hemolysis test:
Assay for hemolytic properties of the volatile oil was conducted as previously described [42] . In 200 µL of 4% red blood cell suspension (in sterile 5% glucose solution) serial dilutions of the volatile oil (0.00114 to 2.5 µL/mL) and reference drugs (50-1000 µg/mL) were prepared, and the plates incubated at 37°C. After 2 h of incubation, the suspension was centrifuged at 1,000 g for 10 min, and 100 µL of the supernatant transferred to a 96 well plate for absorbance measurement at 540 nm using a Victor 3 Multilabel Reader (PerkinElmer). Hemolytic effect was expressed as percentage of the absorbance of the positive control (Triton X-114, 5 µL/ mL).
Statistical analysis:
The median effective concentration (EC 50 ) for antiamastigote assay, median cytotoxic concentration (CC 50 ) for cytotoxicity assay on the THP-1 cells and median lethal concentrations (LC 50 ) for hemolysis assay were all evaluated from sigmoidal dose-response curves using non-linear regression software (GraphPad Prism ® ; GraphPad Software, Inc., San Diego, CA), each expressed as mean ± SD from triplicate experiments with each test concentration in duplicate.
